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Abstract
Background: Acute hypoxic/ischemic insults to the forebrain, often resulting in significant cellular loss of the cortical
parenchyma, are a major cause of debilitating injury in the industrialized world. A clearer understanding of the pro-death/
pro-survival signaling pathways and their downstream targets is critical to the development of therapeutic interventions to
mitigate permanent neurological damage.
Methodology/Principal Findings: We demonstrate here that the transcriptional repressor ZEB1, thought to be involved in
regulating the timing and spatial boundaries of basic-Helix-Loop-Helix transactivator-mediated neurogenic determination/
differentiation programs, functions to link a pro-survival transcriptional cascade rapidly induced in cortical neurons in
response to experimentally induced ischemia. Employing histological, tissue culture, and molecular biological read-outs, we
show that this novel pro-survival response, initiated through the rapid induction of p63, is mediated ultimately by the
transcriptional repression of a pro-apoptotic isoform of p73 by ZEB1. We show further that this phylogenetically conserved
pathway is induced as well in the human cortex subjected to episodes of clinically relevant stroke.
Conclusions/Significance: The data presented here provide the first evidence that ZEB1 induction is part of a protective
response by neurons to ischemia. The stroke-induced increase in ZEB1 mRNA and protein levels in cortical neurons is both
developmentally and phylogenetically conserved and may therefore be part of a fundamental cellular response to this
insult. Beyond the context of stroke, the finding that ZEB1 is regulated by a member of the p53 family has implications for
cell survival in other tissue and cellular environments subjected to ischemia, such as the myocardium and, in particular,
tumor masses.
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Introduction
Hypoxic/Ischemic (H-I) insult to the CNS is an important cause
of neurological morbidity, with severe cases resulting in life-long
deficits [1,2]. Stroke is a leading cause of death in adults, and
increasingly sophisticated imaging technologies reveal that the
incidence of stroke in infants (particularly premature babies, 1 in
greater than 4000 births) now rivals that seen in the over-70
population [3,4]. Whatever the developmental time frame, H-I
insult to the brain results in a net loss of both neuronal and glial
cells through both apoptotic and necrotic mechanisms [for
reviews, see 5 and 6]. Although developmental distinctions clearly
exist in the molecular etiology of H-I lesions, our understanding of
these molecular events is woefully incomplete [7,8].
The development of the cerebral cortex is an extraordinarily
dynamic process, involving the migration, proliferation and
turnover of vast numbers of cells [9]. A critical part of this process
is the regulated elimination of excess neurons and glia through
programmed cell death [10]. Histological studies in embryonic
mice reveal a tremendous amount of cellular death in the
developing cortex, in both neural progenitor and newly born
neuronal populations, peaking at roughly 70% of the total cell
number around embryonic day 14, and declining thereafter [11].
Work from a number of labs has implicated the involvement of
transcriptionally active isoforms of p53 and p63 in this process
[12,13] and TAp63 has additionally been shown to be required for
growth factor-deprivation-mediated apoptosis of developing sym-
pathetic neurons [14]. The deltaN isoforms of p63 and p73
(functioning as dominant negative inhibitors of their transcrip-
tionally active counterparts) are, as well, required for post-natal
survival of both sympathetic and CNS neurons [15,16,17].
Whatever the mechanistic basis, proper development requires
PLoS ONE | www.plosone.org 1 February 2009 | Volume 4 | Issue 2 | e4373that cells of the immature cortex be biochemically and genetically
primed to receive and readily respond to pro-death signaling,
rendering them particularly vulnerable to H-I episodes.
ZEB1/delta EF1, a phylogenetically conserved DNA-binding
transcriptional repressor, has been implicated in the regulation of a
number of basic-Helix-Loop-Helix (bHLH; e.g. MASH1) target
genes [18,19,20]. Such a role is not, however, supported by the
phenotype of the ZEB1 KO mouse, in which bHLH-triggered
differentiation programs appear unaltered. Rather, at birth, ZEB1
knockout mice are about one-third to one-half proportionately
smaller in size than their heterozygous or wild-type littermates [21],
consistent with it playing a role in cellular survival (and/or in
regulation of the cell cycle). Here, we present data that strongly
supports such a role for ZEB1 in neuronal survival in the context of
ischemic insult in the CNS, by serving as a critical link in a
transcriptional cascade involving pro-apoptotic isoforms of p63 and
p73. Specifically, we demonstrate that ZEB1 protein expression
levelsincorticalneuronsinvivo arehighlyinduced earlyinresponse
to the experimental administrationof permanentunilateralstrokein
both the developing and mature brain. Similar levels of induction of
human ZEB1 protein are seen in cortical samples derived from
pathology specimens of stroke victims. Over-expressed ZEB1 is
protective in primary cortical neurons subjected to oxygen-glucose
deprivation (OGD), while, conversely, primary cultures of cortical
neurons from ZEB KO mice are over twice as vulnerable to this
insult. The ischemic increase in ZEB1 results, in part, through
transcriptional induction by p63, itself induced early in response to
stroke. We show further that the neuro-protective effects mediated
by this increase in ZEB1 protein are the consequence, at least in
part, of its binding to and repressing the TAp73 gene. This is the
first demonstration, through the elucidation of this novel transcrip-
tional cascade, of a functional role for ZEB1 in cell survival, and in
neuronal protection in particular.
Results
ZEB1 protein is rapidly induced in cortical neurons by
ischemia
A recent report demonstrating that a shift in intracellular redox
levels to a net reducing environment (for example, as a result of
hypoxia) dramatically increased the functional activity of a ZEB1
co-repressor, C-terminal binding protein 1 [CtBP1; 22], prompted
us to ask whether ZEB1 may itself be subject to regulation by O2
levels in the brain. As a first approach, we subjected primary
cultures of neurons isolated from cortexes of E16.5-E17.5 rats to
OGD for various times, and immuno-stained them for ZEB1
expression. The proportion of neuronal cells in these cultures was
assessed by immuno-staining a representative culture with appro-
priate anti-neuronal (anti-NeuN or MAP2) or anti-glial (GFAP)
antibodies, and was consistently greater than 95% neuronal (not
shown). As seen in Figure 1, panel I, a 2 hr. exposure to OGD
(,0.5% O2), without subsequent re-exposure to normoxia, induced
a clear increase in the levels of ZEB1 protein in these neurons
compared to normoxic controls (panels b and d vs. c and e).
Western blots on protein isolates from cultures treated in parallel
revealed an average increase in ZEB1 protein levels to be just under
8-fold under these conditions (inset, Figure 1, panel I, e;a
graphic representation of this increase is depicted in panel I,f).
ZEB1 is induced in cortical neurons in vivo in response to
experimentally-induced ischemic stroke
We then asked whether ZEB1 is similarly regulated in vivo as a
consequence of experimentally-induced stroke. Permanent focal
cerebral ischemia (FCI) was induced in P7 rat pups (the
approximate developmental analogue of the human brain near
term; for details, see [23]), via suture embolism of the mid-cerebral
artery, and in adult rats by electro-coagulation of that same artery,
and brains were harvested and processed for immuno-histochem-
istry at various time points following the injury. Beginning about
90 minutes post-op, we detected an average 10-fold increase
(normalized to b-actin levels: see Figure 1, panel II, f) in ZEB1
protein levels in the cortex of the ischemic side (in what appear to be
the internal and external pyramidal cell layers of the cortex,
Figure 1, panel II, a and c). The response in the adult rat brain
was over twice that seen in the neonate, with the area of infarct
more closely confined to the region in the cortex proximal to the
occluded mid-cerebral artery (data not shown). At either stage of
development, in this model of permanent MCAO, increased ZEB1
protein expression in the ischemic cortex persisted for at least
72 hrs., co-incident with the radiating penumbra in the growing
lesion (data not shown). Verification that ZEB1-positive cells in the
ischemic cortex are neurons (likely pyramidal cells, based on their
morphology) was obtained by double-immunofluorescence staining
frozen sections using antibodies specific for ZEB1 and the neuron-
specific marker NeuN (Figure 1, panel III).
Primary neurons from ZEB1 knock-out mice are
significantly more vulnerable to OGD
Miceinwhichthe ZEB1genehasbeendeletedareproportionally
one-half to two-thirds the size of their wild-type littermates [21].
While not dispositive, such a phenotype is consistent with this
transcriptional repressor participating in the regulation of genes
involved in promoting cell death. Further support for such a role
comes from the recent finding that a ZEB1 co-repressor, CtBP1,
can itself repress a subset of pro-apoptotic genes [24, and see
discussion]. If ZEB1 functions, at least in part, as an early defense
mechanism initiated in cortical neurons to promote their survival
following ischemia, ZEB12/2neurons in culture might be more
vulnerable to the approximate tissue culture equivalent, oxygen-
glucose deprivation (OGD). To test this, we isolated primary
cortical cultures isolated from ZEB12/2mouse E16.5 mouse
embryos (as well as from their wt littermates) and subjected them to
this insult. After 6 hrs in OGD, we detected over twice as many
pyknotic/condensed nuclei in ZEB12/2neurons compared with
wt (Figure 2, white bars). Over-expressing ZEB1 via transfection
in these cells rescues their resistance to OGD to levels similar to
transfected wt cells (Figure 2, blue bars).
Although the specific mechanism – apoptosis, necrosis,
autophagy, etc. – depends on many factors, including region of
the brain affected, developmental stage, and the type, degree and
duration of insult, the ultimate pathological consequence of severe,
sustained ischemic insult is cell death [6,7,8]. To address the
potential role of ZEB1 in this process, we asked whether the
ischemia-induced neuronal up-regulation of this protein co-
localized with the induction of specific, well-characterized, cell-
death/survival-related markers. Double-immunofluorescence
staining revealed that, in the ischemic cortex 12 hrs-post insult,
cells staining positive for either active Caspase 3 (Figure S2, top),
or the BH3-only, Bcl-2 family member PUMA (Figure S2,
bottom), both well characterized markers for cells undergoing
apoptosis [25,26], were virtually all mutually exclusive from
ZEB1-positive cells.
Over-expressing ZEB1 protein in primary cortical cultures
protects them from specific pro-death insults
To further test whether ZEB1 protein induction is part of a neuro-
protective mechanism, we scored the relative health of ZEB1-
ZEB Promotes Neuronal Survival
PLoS ONE | www.plosone.org 2 February 2009 | Volume 4 | Issue 2 | e4373Figure 1. Ischemia-mediated induction of ZEB1 protein in cortical neurons. Specificity of the ZEB1 antibody used in these studies is
demonstrated in Figure S1; Panel I. ZEB1 protein levels increase 8-fold in primary cultures of cortical neurons exposed to OGD. Photomicrographs of
E16.5 primary cortical neuronal cultures exposed to normoxia (a,c), or OGD (b,d) for 90 minutes and immuno-stained for ZEB1 protein; (e),
representative western analysis of total protein isolates, Z=ZEB1, A=b-actin, N=normoxia; f, densitometry of the bands from e, normalized to b-
actin; four different replicate samples of cells (isolated on different days) were scored and the average+/2the S.E.M. is shown; Panel II. ZEB1 protein
levels increase over 10-fold in the P7 rat ischemic cortex. Representative photomicrographs of immunostained coronal sections comparing the
ischemic (a,c) and the contra-lateral (b,d) sides of the same sections, harvested 3 hours following administration of unilateral permanent FCI; the
increase is largely confined to the nucleus of cells located mainly in the inner and outer pyramidal cell layers of the cortex; (e), representative western
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two independent histological methods (chosen, in part, because of
their extensive association with stroke-mediated neuropathology and
neuronal cell death): either mitochondrial- (loss of membrane
integrity) or nuclear- (morphological integrity) based. Following
transfection of either a full-length ZEB1-GFP fusion protein or with
GFP alone, cells were challenged with a range of individual insults,
including OGD, and then scored at specific time points for their
ability to resist cellular degradation/death (representative fluores-
cence images from these analyses are shown in Figures S3 [nuclear
morphology] and S4 [mitochondrial membrane integrity]).Asshown
in Figure 3, compared with controls, neurons over-expressing ZEB1
(blue bars) displayed a significantly greater survival capacity, by either
histological measure, in the face of H2O2, glutamate, TNF-a,O D G ,
and ionizing radiation. The lone exception, nitric oxide (NO), has
been studied extensively in both normal and patho-physiological
contexts in the CNS, and, depending on many factors, can mediate
either neuroprotective or neurotoxic effects [45,46]. The NO result is
especially interesting given that over-stimulation of NMDA receptors
via excitotoxic insult has been shown in cortical neurons to increase
(via calcium-mediated activation of neuronal nitric oxide synthase
(nNOS)) intracellular levels of NO-derived reactive nitrogen species,
which potentially can play a role in subsequent cellular damage and
death [45–49]. Whether the failure of ZEB1 to mitigate or delay the
NO-mediated toxicity seen in the context of the relatively pure
primary neuronal cultures employed here can offer any mechanistic
insight into ZEB1’s neuroprotective effects will depend on a number
of factors (see discussion).
We then followed a time course of ZEB1-mediated protection of
neurons in culture from the introduction of double-stranded DNA
breaks – a classic hallmark cellular injury/death – resulting from
oxygen-glucose deprivation, one of the critical injury-inducing
consequences of in vivo ischemic episodes. Significant protection
(greater than 2-fold) was achieved at least 6 hrs following the
administration of this insult, as revealed through TUNEL staining
(Figure S5).
Figure 2. Primary cortical cultures derived from ZEB1 KO or wt E16.5 embryos were transfected with either a GFP expression vector
(control, White Bars), or a plasmid expressing a full-length ZEB1 cDNA fused to GFP (Blue Bars). Sixteen hours later, cells from both
groups were subjected to OGD for 6 hrs, fixed under hypoxia, the nuclei were Hoechst-stained and then scored (in a blinded fashion) for presence of
either a normal vs pyknotic/mis-shapen/condensed morphology. Over twice as many pyknotic nuclei were scored in ZEB KO cells as compared to
their wt counterparts. Insert shows a representative western blot verifying the absence of ZEB1 protein in neurons derived from the KO animal. Lower
bands are the loading control b-actin. Over-expressing ZEB1 cDNA conferred a similar increase in resistance above wt (Blue Bars) on neurons of either
genotype. Four different replicate samples of cells (isolated on different days) were scored and the average+/2the S.E.M. is shown; Z, ZEB1; A. b-actin;
*=P,0.05, by Student’s t-test.
doi:10.1371/journal.pone.0004373.g002
analysis of total cortical protein isolates; f, densitometry of the bands from (e), normalized to b-actin; N=normal brain, S=sham, C=contra-lateral,
I=ischemic; Graph depicts the average of at least three separate experiments, and the average+/2the S.E.M. is shown; Panel III. Cells up-regulating
ZEB1 in the ischemic cortex co-localize with the neuronal marker NeuN. Representative staining of 8 mm coronal sections from P7 rat pup brains
harvested 12 hrs. post-FCI. Scale bars: panel I: a,b, 250 mm; c,d, 100 mm; panel II: a,b, 1 mm; c,d, 50 mm; panel III: 50 mm. **=P,0.01, by Student’s t-
test.
doi:10.1371/journal.pone.0004373.g001
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by ischemia-induced p63
Quantitative real-time-PCR (qRT-PCR) indicated that approx-
imately 70% of the increase in ZEB1 protein levels seen in OGD-
treated primary neurons could be ascribed to an induction in the
steady-state levels of ZEB1 message (Figure S6). A computer-
based search [27] for transcription factor-binding sites within the
immediate-upstream regulatory region (proximal promoter) of the
ZEB1 gene revealed the presence of a phylogenetically-conserved
p53-family binding site. Given the well-established roles that p63
Figure 3. Over-expressed ZEB1 protects primary cortical neurons from a subset of pro-death insults. E16.5 primary cortical neurons
transfected with GFP or ZEB1 fused in frame to GFP (for a 30 hr period) were subjected to the following pro-death agents for the indicated times:
Veh., DMSO; H2O2, hydrogen peroxide (6 hrs); Glu, glutamic acid (18 hrs); NO, nitric oxide (20 hrs); TNF-a, tumor necrosis factor alpha (18 hrs); OGD,
oxygen-glucose deprivation (12 hrs); IR, ionizing radiation (6 hrs). At indicated time points, cells were fixed, processed and their ability to resist
cellular degradation/death was assessed using two distinct markers of cellular degradation or death. Representative fluorescence images from these
analyses are shown in Figures S3 (nuclear morphology) and S4 (mitochondrial membrane integrity). Top graph: in every case except for NO, at a given
concentration/level of the indicated treatment, and at the time points examined, on average, less than half as many nuclei in neurons over-expressing
ZEB1 showed a shrunken/pyknotic/condensed morphology compared with their GFP-expressing counter-parts. Bottom graph: in every case except
for nitric oxide, at a given concentration/level of the indicated treatment, and at the time points examined, on average, over twice as many ZEB1-
over-expressing neurons maintained intact mitochondrial membranes compared with their GFP-expressing counterparts. Results shown above are
averaged from at least three separate experiments (cultures isolated on different days)+/2the S.E.M. **=P,0.05 by ANOVA.
doi:10.1371/journal.pone.0004373.g003
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PNS neurons [16,17; for review, see 14], we asked whether a
member of the p53 family might, through direct regulation of the
ZEB1 gene, participate in the determination of the survival
outcome of cortical neurons subjected to ischemic insult.
Similar to previously published results employing an adult rat
stroke model [28], an increase in p53 protein itself was not
observed histologically in the ischemic cortex until at least 6 hrs
post-insult (data not shown). p73 protein expression increased
slightly one hr post-insult, and continued to increase, reaching a
plateau at around 3 hrs post-insult. p63 protein was induced even
earlier, within at least one hr following the ischemic injury
(Figure 4A). Double immuno-fluorescence staining showed that
the induction of both p63 and p73 protein co-localized with that of
ZEB1 protein in cortical neurons (Figure 4B). Western analysis of
total cellular protein lysates from ischemic vs normal or sham
operated P7 rat cortexes showed that the TAp63, DNp63, and
DNp73 protein isoforms all increased over the 6 hr time period
examined, with the DNp63 isoform increasing the most rapidly,
within one hour post-insult (Figure 4C). Interestingly, the pro-
apoptotic TAp73 isoform [29], following an initial increase,
decreased between 3 and 6 hrs post-insult (Figure 4C), co-incident
with the steadily increasing levels of ZEB1, DNp63, TAp63 and
DNp73.
These temporal protein induction profiles suggested that p63
might participate in the transcriptional up-regulation of the ZEB1
gene through the DNA binding site described above. To address
this question, we analyzed total RNA isolates from normal, sham-
operated and ischemic cortexes at 1, 3 and 6 hrs post-insult for the
presence of various p63 mRNA isoforms via RT-PCR. While the
DN, 63a and p63c isoforms all increased slightly over the 6 hr
period, the p63b isoform rose dramatically (Figure 4D).
Transactivation analysis, coupled with DNA-binding assays
revealed that TAp63a, TAp63b and DNp63b could both bind and
transactivate the ZEB1 promoter through the above site
(Figure 5B and C). To verify whether and to what extent p63
participates in the OGD-mediated increase in ZEB1 protein, we
reduced endogenous p63 levels in primary cultures of mouse
cortical neurons via lentiviral-mediated SiRNA [30] and measured
ZEB1 protein induction in control vs OGD-treated cells. The
results (Figure 6A, shown graphically in 6B) demonstrate that, in
this experimental context, DNp63 accounts for roughly 60% of
ZEB1 protein induction (see also Figure 4C and D). Interest-
ingly, in control experiments with (Figure 6A) or without (not
shown) scrambled SiRNA transduced into primary cultures of
ZEB2/2neurons (maintained in the presence of the pan-Caspase
inhibitor z-VAD-fmk), not only was the reduction in TAp73
protein levels between 3 and 6 hrs of OGD treatment (as occurs in
a wt ZEB1 background) virtually eliminated, but the OGD-
mediated induction of DNp63 protein – about seven-fold in a wt
ZEB1 background – was itself reduced by half (see discussion).
Lastly, we demonstrated in vivo binding of p63 to the ZEB1
promoter (in the ischemic cortex vs. sham operated), employing a
pan-p63 antibody (recognizing all isoforms) in a chromatin
immunoprecipitation (ChIP) assay (Figure 6C).
ZEB1 represses the pro-apoptotic p73 isoform in
response to FCI
Not only does TAp73 participate in the apoptotic elimination of
excess neurons in the developing CNS and PNS [for review, see
14], but ZEB1 has been demonstrated to repress the p73 gene (by
binding to a silencer region in the first intron of the human
homologue of that gene) in an in-vitro model of neuronal
differentiation [31]. These findings, together with the above data,
compelled us to explore the regulatory link between ZEB1 and
p73 in ischemic neurons by asking whether the protective effect of
ZEB1 is mediated, at least in part, through its repressing the p73
gene. We addressed this by comparing mRNA expression profiles
of ZEB1, TAp73a and DNp73 in the P7 cortex in the immediate
post-ischemic (6 hr) time frame. Consistent with our analyses at
the protein level (Figures 4C and 6A), the steady-state levels of
TAp73 mRNA begin to decline as ZEB1 mRNA levels are seen to
rise (between 90 mins and 2 hrs post-insult; Figure 7A, summa-
rized graphically in Figure 7B). Coincident with this, steady-state
levels of the pro-survival DNp73 isoform [15,16] mRNA levels
begin to rise after about 2 hrs. Using OGD-treated vs. normoxic-
treated primary cultures of human embryonic cortical neurons, a
ChIP assay showed that ZEB1 does indeed bind to the previously
characterized intron 1 silencer region of the human p73 gene in
response to this insult (Figure 7C). To demonstrate this point
further, we were able to rescue the OGD-mediated down-
regulation of TAp73 protein, by re-introducing ZEB1, via
lentiviral transduction, back into cortical neurons isolated from
E16.5 ZEB1 knock-out mouse embryos (Figure 7D). Together
with our data showing that p73 protein levels fail to decline in
OGD-treated ZEB2/2neurons (Figure 6A), these results are
consistent with ZEB1 playing a direct role in repressing the p73
gene, offering one mechanistic basis for it’s protective effect.
ZEB1 protein is up-regulated in the human brain in
response to ischemic stroke
Lastly, we investigated whether the ischemia-mediated increase
in ZEB1 protein levels has a clinical correlate by staining (in a
blinded fashion) archived cortical tissue obtained from autopsies of
patients having a clear diagnosis of an acute ischemic episode,
compared to those presenting with no such evidence. Represen-
tative staining patterns derived from two individuals are shown in
Figure 8A. The intensity and localization of ZEB1 staining in the
cortex from the premature infant diagnosed with gross cranial
hemorrhagic ischemia (bottom row) is very similar to that seen in
the P7 rat cortex (Figure 1, panel II). In contrast, the staining
intensity in sections derived from the cortex of a patient having no
evidence of ischemia-based neuropathy was relatively faint
(Figure 8A, top row). The statistical results derived from a total
of 71 different patient samples, demonstrated a highly significant
association between ZEB1 protein induction and a diagnosis of an
acute ischemic episode (Figure 8B).
Discussion
A clearer understanding of the pro-survival signaling pathways
and their downstream targets triggered by ischemia in cells of the
cortical parenchyma is critical to the eventual development of
therapeutic interventions to mitigate permanent neurological
damage. The data presented here provide the first evidence that
the transcriptional repressor ZEB1: 1) is dramatically induced in
response to experimentally-administered permanent stroke, as well
as in the human cortex in response to clinically relevant acute
ischemic episodes; 2) can protect primary neuronal cultures
against OGD and other pro-death insults; 3) decreases neuronal
vulnerability to OGD in a dose-dependent fashion; 4) is itself
transcriptionally up-regulated by p63 in this pathological context;
5) may inhibit, mitigate or delay neuronal apoptosis in an acute
time frame by repressing TAp73. The stroke-induced increase in
ZEB1 mRNA and protein levels in cortical neurons is both
developmentally and phylogenetically conserved and may there-
fore be part of a fundamental cellular response to this insult.
Beyond the context of stroke, the finding that ZEB1 is regulated by
ZEB Promotes Neuronal Survival
PLoS ONE | www.plosone.org 6 February 2009 | Volume 4 | Issue 2 | e4373Figure 4. p63 is rapidly induced in response to ischemia. (A) Expression profile of p63, p73 and ZEB1 protein induction in the ischemic cortex
of P7 rat pups subjected to FCI. Brains were harvested and processed for immunostaining at the indicated time points post-FCI. Colorimetric staining
reveals that p63 is induced the earliest, at least one hr post-FCI. Scale bar=500 mm. (B) Both p63 and p73 induction co-localize with that of ZEB1.
Double-immuno-fluorescence staining indicates that all three of these proteins co-localize to neurons in the ischemic cortex. In all cases, staining was
carried out at least three times and typical results are shown. Scale bars, a., 500 mm; b., 50 mm. (C) Western analysis of the induction of p63 and p73
isoforms compared to ZEB1. Total cellular protein was isolated from normal (N), sham operated (S – 6 hr time point), or ischemic cortexes at the
indicated time points following administration of FCI. All show some degree of up-regulation in this immediate time frame, except for TAp73, which
after an initial rise, declines between 3 and 6 hrs post FCI. b-actin is included as a loading control. Shown is a typical result from separate analysis of
three different experiments. (D) RT-PCR analysis of temporal expression of p63 isoforms in the cortex immediately following FCI. Primer pairs (see
Materials and Methods) were designed to specifically amplify the isoform classes indicated but could not distinguish whether a particular 39 splicing
variant (abor c) harbored the TA or the DeltaN 59 end. While p63 TA, alpha and gamma both showed a modest increase in the six-hr period
immediately following FCI, the beta isoform showed a dramatic induction. Positive controls are shown in the first two lanes in the top panel and in
the first three lanes in the bottom panel. Sizes of PCR products are indicated on the right.
doi:10.1371/journal.pone.0004373.g004
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PLoS ONE | www.plosone.org 7 February 2009 | Volume 4 | Issue 2 | e4373Figure 5. p63 binds and transactivates through a phylogenetically conserved binding site in the proximal promoter region of the
ZEB1 gene in response to ischemia. (A) Schematic of the promoter regions of human (H) mouse (M) and rat (R) ZEB1 genes. The binding site in
the rat gene is shown, with the bases differing from the p53 binding site consensus sequence shown in red. (B) Specific p63 isoforms can
transactivate the ZEB1 promoter. The listed p63 isoform cDNAs were co-transfected into the p63-null cell line Saos-2 along with a luciferase reporter
plasmid driven by the fragments (listed in the right panel insert) of the mouse ZEB1 promoter. The luciferase activity derived from the co-transfection
of TAp63a, TAp63b and DeltaNp63b isoforms was dependent on the p53 binding site, the mutation of which abrogated this activity (gray bars); insert
is a western blot derived from equal amounts of protein lysates from parallel transfected cultures using a pan-anti-p63 antibody (identity of bands
follows the same order, left to right, as the transfection data). (C) Equimolar amounts of protein derived from in vitro translated p63 isoform cDNAs
were used in a micro-titre-based DNA-binding assay employing oligonucleotides harboring the site shown in panel (A) (see Materials and Methods).
With the exception of the DeltaNc isoform, all bound specifically to the site in the rat promoter. Competitor oligos are identified in the panel insert.
doi:10.1371/journal.pone.0004373.g005
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other tissue and cellular environments subjected to ischemia, such
as the myocardium [for review, see 32] and, in particular, tumor
masses [for review, see 33]. This is the first report ascribing a role
for ZEB1 in cellular survival, substantiating a recent report by
Grooteclaes et. al., showing that one of ZEB1’s co-repressors,
CtBP1, itself has anti-apoptotic activity [24, and see below]. In
addition, to our knowledge, this is also the first report to suggest a
role for p63 in cell survival in the ischemic CNS. Finally, these
data provide a plausible mechanistic basis for the phenotype of the
proportionately undersized ZEB1 knockout mouse.
While our understanding at the molecular level is incomplete,
the well documented cellular responses to ischemia include the
rapid depletion of ATP stores with a concomitant shift in the redox
state, creating an overall reducing environment that affects
virtually all aspects of cellular metabolism and physiology, from
gene expression patterns to energy use and production [5,6,34].
Using cell culture conditions similar to those we employed here,
Zhang et. al. recently demonstrated that a ZEB1 co-repressor,
CtBP1, can, by virtue of its use of NAD(P)H as a co-factor, sense
very subtle alterations in the cellular redox potential, as manifest in
the ratio of NAD(P)+ to NAD(P)H. Binding of NAD(P)H to CtBP1
significantly increases the affinity of CtBP1 for ZEB1, increasing
proportionately the ability of this complex to repress target genes
[22]. In light of these data, our finding that ZEB1 protein levels
increase by an order of magnitude in rat cortical neurons in
response to the reducing environment created by permanent FCI
(Figure 1, panel II), as well as the human cortex in response to
acute ischemic episodes (Figure 8), suggests that multiple
pathways converge to prevent ZEB1-target genes from being
activated. We note here that protein levels of the other, well-
characterized member of the zinc-finger homeodomain (ZFHX1)
family, Smad-Interacting Protein 1 [SIP1, ref. 44] was, itself, up-
regulated, in both juvenile and adult rats, an average 2-3-fold in
the ischemic cortex in our permanent stroke model (data not
shown). Over the last several years, a number of groups have
described the involvement of ZEB1 (ZFHX1A) and SIP1
(ZFHX1B) – both individually and cooperatively – in the
transcriptional repression of the E-cadherin gene during the
epithelial-to-mesenchymal transition of carcinoma cells subjected
to the low oxygen/ischemic/reducing environment in the interior
of a growing tumor mass (a necessary step in the progression of
tumors towards metastasis, [refs. 51–54]). We are currently
examining the relative contribution that each of these two closely
related transcriptional repressors makes, individually and together,
to cellular survival in response to hypoxic/ischemic challenge.
In light of the entirety of the data presented here, it will be
clearly important to know not only how long ZEB1 induction
persists beyond the 72 hr period we observed histologically (in
both the neonatal and adult rat cortex, data not shown), but to
Figure 6. OGD-mediated ZEB1 protein induction depends significantly on p63. (A) Primary cortical cultures from either wt or ZEB1 KO mice
were transduced with lentiviral constructs expressing either scrambled or p63 SiRNA (see Materials and Methods for sequences). Western blots of
protein lysates prepared at indicated time points were carried out using antibodies shown at left. Densitometry of normalized (to b-actin) expression/
induction profiles are depicted graphically in (B). Results are representative of 3 separate experiments, carried out on independent primary neuronal
isolates (done on different days). At the 3 hr time point, SiRNA-mediated reduction in p63 protein levels reduces OGD-mediated ZEB1 protein
induction an average 60% (ZEB1 graph). The reduction in p73 protein levels in wt neurons between 3 and 6 hrs following OGD (see Figure 4, panel C,
and the top panel of westerns, labeled: ‘‘wt cells+scrambled SiRNA’’ in this figure) is virtually eliminated in the absence of ZEB1 (TAp73 graph).
Interestingly, the dramatic increase in OGD-mediated DNp63 protein levels (seen in the top panel of westerns, labeled: ‘‘wt cells+scrambled SiRNA’’)
was reduced by half in a ZEB1 KO background (see text). (C) ChIP assay using the pan-anti-p63 antibody (recognizing all isoforms in the transfection
analysis, Figure 5, panel B) shows that, in the cortex, within 1 hr of FCI, p63 binds to the site depicted in Figure 5, panel A in vivo. Primers used are
depicted schematically (in green) in Figure 5, panel A. Tubulin, negative control ChIP using heterologous anti-Tubulin Ab; Pos. Cont., PCR product
from post-IP supernatant harboring p63 binding sites (see Methods). Error bars: S.E.M. *=p,0.01; **=p,0.001.
doi:10.1371/journal.pone.0004373.g006
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PLoS ONE | www.plosone.org 10 February 2009 | Volume 4 | Issue 2 | e4373map out the regional and cellular specificity of this induction with
respect to the expanding ischemic lesion. Further, in the context of
a mild ischemic episode, or experimental pre-conditioning, is
ZEB1 induced, and does evidence of persistent induction correlate
with the protective effects of these mild insults?
The importance of maintaining certain ZEB1-target genes in
the off state in this context is underscored as well by our finding
that primary cortical neurons isolated from ZEB KO mice are
over twice as sensitive to OGD as their wt counterparts (Figure 2).
This is further reinforced by a recent microarray-based study from
the laboratory of Frisch (in the context of tumor progression),
demonstrating that CtBP1 can target a number of epithelial-
specific and pro-apoptotic-specific genes, and, potentially, play a
key role in the epithelial-to-mesenchymal transition in the
relatively hypoxic interior of a tumor mass [24].
Over-expressed ZEB1 was able to protect cortical neurons in
culture from a number of biologically-relevant insults with the
exception of the widely studied neurotransmitter/regulatory
molecule nitric oxide (Figure 3). This result is important not
only because of the well established role of NO in a wide variety of
normal and patho-physiological processes, including many
neurodegenerative diseases and stroke [47,48], but as well may
offer a clue about the mechanistic basis for ZEB1’s neuroprotec-
tive activity. At lower or physiological levels, NO itself has been
shown to be neuroprotective, while intermediate and higher levels
can cause apoptosis and necrosis, respectively [45,46,49]. In
addition, as with any bio-active agent, the ultimate effect of NO
will depend on many factors, such as neuronal cell-type, age of the
culture, percentage of glial cells, media components, source and
half-life of the NO-donor, cellular redox state, etc.
Regardless of the experimental conditions, it is interesting that
ZEB1 could protect our cortical cultures from an insult –
excitotoxicity – which is known to trigger an nNOS-mediated
increase in intracellular NO/reactive nitrogen species, but not
from a direct challenge with nitric oxide itself (Figure 3 and see
corroborating data in Figures S3, S4 and S5). One possible
explanation for this result is that the levels of reactive nitrogen
species generated in our excitotoxicity experiments fell below the
threshold that can overcome ZEB1 protection – a level clearly
attained in the experiments in which an NO donor was
administered alone. Primary cultures of cortical neurons do not
become sensitized to excitotoxic insult until they have expressed at
Figure 8. ZEB1 protein is up-regulated in the human brain in response to ischemic insult. Panel I. Representative staining of thin sections
of cortical brain tissue derived at autopsy from patients whose cause of death was diagnosed as either ‘sepsis and prematurity’’ (top row) or
‘‘extensive germinal matrix hemorrhage with interventricular extension and infarction’’ (bottom row). General cellularity and morphology is revealed
through H and E staining (a,d). Adjacent sections stained for ZEB1 protein expression shows a clear up-regulation in the developing cortical region in
the patient diagnosed with hemorrhagic ischemia (e), in a pattern similar to that seen in the experimentally-induced ischemic cortex of the P7 rat pup
(Figure 1, panel II). Magnification of the corresponding sections demonstrates the nuclear localization and intensity of ZEB1 staining in the ischemic
tissue (f), while levels in the non-ischemic brain remain at background (c). Scale bars=a,b,d,e.=500 mm, c,f.=50 mm. Panel II. Chi-squared analysis of
the data indicates that the association of ZEB protein induction with the diagnosis of an acute ischemic episode is highly significant.
doi:10.1371/journal.pone.0004373.g008
Figure 7. ZEB1 represses TAp73 in the cortex in response to ischemic insult. (A) Agarose gel of RT-PCR analysis of cDNA synthesized from
total RNA isolated at the indicated time points from either Sham-operated (S) or FCI (I) P7 cortexes. The numbers in parentheses on the left (below
the indicated PCR product) denote the number of PCR cycles used to achieve linear-range amplification of each target. Shown is a representative
result from one of three independent experiments (each derived from a separate litter). To control for the presence of contaminating genomic DNA, a
PCR-only reaction using identical conditions was carried out using these samples (not shown). (B) For each experiment, a numerical value for relative
intensity was obtained by densitometry, and after normalization to the levels of b-actin (bottom row, panel a) Sham (background) values were
subtracted from the corresponding Ischemic values. The average of these results from all three RT-PCR analyses are depicted graphically as the
average value+/2the S.E.M. Two hours after the administration of FCI, steady-state levels of ZEB1 mRNA (black squares) are beginning to plateau,
those of TAp73 (green circles) are declining, while DNp73 levels are increasing. (C) ChIP analysis showing increased ZEB1 protein binding to the
previously characterized silencer region within intron 1 of the human p73 gene, beginning one hour after primary cortical neurons were subjected to
OGD, and increasing significantly at three hours. Results shown are representative of three separate experiments. (D) Rescue of ZEB1-mediated
repression of p73 protein levels. Primary cortical cultures isolated from ZEB1 knock-out late stage embryos were transduced with a lentivirus
harboring either GFP (‘‘Control Transduc’’, top) or ZEB1 fused to GFP (‘‘ZEB1 Rescue’’, bottom). The top three panels in (D) were derived from a
(representative) single western blot, and the bottom three panels from a different (representative) single western blot, each the product of one of
three separate experiments (cultures isolated on different days). Restoration of ZEB1 re-established the OGD-mediated reduction in TAp73 protein
(see Figure 4 Panel C, Figure 6, panel A).
doi:10.1371/journal.pone.0004373.g007
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minimize the possible influence of culture-derived excitotoxic
effects (e.g. NMDA receptor mediated induction of nNOS, [refs.
47, 50]) primary cortical neurons were challenged with the NO
donor between 4 and 6 DIV. As ZEB1 can protect against reactive
oxygen species (ROS) derived from administration of H2O2 to
these cultures, it is possible that under the conditions we employed
here, the ROS generated as a result of excitotoxic challenge
predominates over NO-derived reactive nitrogen species.
While the NO-donor compound, S-nitroso-glutathione
(SNOG/GSNO), had clear neuro-toxic effects at the concentra-
tion employed here (250 mM), it’s relatively long half-life
(compared to other NO donors) may have contributed both to
it’s toxicity, and it’s potential for non-physiological nitroslyation.
Nitric oxide-mediated nitrosylation of cysteine sulfhydryl groups
has been shown to occur on and regulate the activity not only of
NMDA receptors, but of various other ion channels, signaling
intermediates, enzymes and transcription factors [48]. It is
therefore possible that NO could nitrosylate ZEB1 itself (for
example, on cysteine residues in the zinc-finger DNA-binding
domains) disrupting it’s functional (and hence, neuro-protective)
activity by, for example, disrupting its binding capacity/specificity,
etc.). Even if such a modification were a normal regulatory
component of ZEB1 activity, it would likely be amplified to a
patho-physiological extreme as a consequence of mass action
resulting from the experimental introduction of high levels of both
NO (via addition of an NO donor) and ZEB1 (via transfection of
an expression vector). Similar non-physiological nitrosylation
reactions have been shown in some cases to cause recipient
protein mis-folding and precipitate an apoptotic cellular response
[46,48]. Such a covalent modification could, as well, simply result
in a loss of function (e.g. a regulatory off switch) that reduced or
eliminated ZEB1’s neuroprotective capacity. Further experimental
approaches are clearly warranted to determine the mechanistic
basis for the ZEB1 – NO relationship.
The p63RZEB1xp73 transcriptional cascade described here
parallels recent results demonstrating a role for another well-
characterized E-box-binding zinc-finger transcriptional repressor,
SLUG, in protecting hematopoietic precursor cells subjected to low
levels of ionizing radiation. In that case, radiation-induced p53
transcriptionally activates SLUG, which, after binding to the
PUMA promoter, blocks subsequent p53-mediated up-regulationof
that gene, allowing these cells to survive a relatively mild insult [35].
Our finding that the p63b mRNA is induced in response to
ischemia to an extent far greater than the other isoforms
(Figure 4D) is particularly interesting in light of the results of
Jacobs et. al. in their recent analysis of growth factor-withdrawal-
mediated apoptosis of sympathetic neurons [17]. In that report,
withdrawal of nerve growth factor (NGF) caused the up-regulation
of the gamma isoform of p63 (albeit with slower kinetics, 22 hrs
after withdrawal before the visualization of p63c protein
induction), while beta isoform levels remained relatively constant.
Whether stroke-mediated recruitment of the beta splicing variant
is related to cell type (cortical neuron vs. sympathetic), or insult
(ischemia vs. growth factor withdrawal), is unknown at present.
Our analysis of the functional activity of p63 on the ZEB1
promoter showed that both the TAb and DNb isoforms could bind
to and transactivate through their cognate site in the ZEB1
promoter. While TAp63c did show binding activity, neither the
TAc nor DNc isoforms showed any significant trans-activity
(Figure 5B and 5C). As the antibody employed in the anti-p63
ChIP assay (monoclonal 4A4) recognizes an epitope common to all
p63 isoforms, we do not know, as yet, which (or which
combination) binds to the ZEB1 promoter in vivo.
Our results using SiRNA on primary cortical neurons derived
from either wt or ZEB1-null mice (Figure 6) demonstrate that
approximately 60% of OGD-mediated induction of ZEB1 can be
attributed to p63. Surprisingly, the OGD-mediated induction of
DNp63 (about seven-fold) is itself reduced by half in the absence of
ZEB1 (Figures 6a and 6b), suggesting the existence of a positive
regulatory feed-back loop between these proteins, though the
mechanistic basis for this (ZEB1 represses a repressor of p63?)
remains to be determined. In the aggregate, these data not only
reinforce the existence of the ischemia/OGD-mediated regulatory
links we have established here between p63, ZEB1 and p73, but
imply a further feedback loop between either ZEB1 or p73 and p63.
In the hours immediately following the onset of ischemia, our
data indicate as well that the protein levels of the (generally) pro-
survival DN isoforms of both p63 and p73 increase relative to the
(generally) pro-apoptotic TA isoforms (Figures 4C, 4D and 6A).
While the mechanistic basis for this is at present unknown, our
data suggest that the ischemia-mediated transcriptional repression
of TAp73 by ZEB1 may be critical to establishing a DNp73/
TAp73 ratio that favors, at least in an acute time frame, a pro-
survival outcome.
Although the mechanism(s) of cell death – apoptosis, necrosis,
autophagy, or a hybrid or combination of these – remains a matter
of debate, an emerging consensus in the literature maintains that
apoptosis plays a more significant role in ischemic injury in the
developing brain, with necrosis becoming the more predominant –
though not exclusive – form in the mature brain [6,7,8]. At either
stage of development, we have demonstrated here that the
ischemia-mediated induction of a novel neuro-protective protein
– ZEB1 – is an early event, occurring as early as 90 minutes after
the ischemic insult (Figures 1 and 4).
As in the case of the well-studied p53-regulated response to
environmental insults, the ultimate fate of a neuron challenged
with ischemia depends on whether the integration of signaling
events and the subsequent genetic response exceeds the threshold
required to precipitate a death response. Our finding that p63 is
induced early in the ischemic cortex and initiates a transcriptional
cascade that manifests, ultimately, in an increase in the ratio of
pro-survival DNp73 to the pro-apoptotic TAp73, may provide one
mechanistic basis for how a neuron might survive a mild ischemic
episode. In a severe, prolonged stroke, this rapidly-induced cellular
defense response (analogous to the parallel up-regulation in
neurons of the pro-survival Erythropoietin receptor [36]), will, of
course, be overwhelmed by the weight of pro-death signaling (as
well as the depletion of cellular ATP). In this case, our data [and
that of others, 15, 16, 17] imply that one major influence on
neuronal fate in the ischemic CNS will be the effective ratios
between the pro-survival and pro-apoptotic isoforms of both p63
and p73, and suggests that ZEB1 plays a role in the transmission of
this survival response. Based on our current detailed understand-
ing of how p53 family isoforms can transcriptionally cross-regulate
and hetero-tetramerize with one another [for review, see 37],
however, it is likely that the regulatory cascade we describe here is
far more complex. A direct role for the DN isoform of p63 in the
repression/inhibition of pro-apoptotic p73 has recently been
described in the context of squamous cell carcinoma [30].
The findings presented here raise several questions. First, is
ZEB1 involved in the well-documented protective effect conferred
on the CNS, myocardium, and other tissues by ischemic pre-
conditioning [38,39]? Second, in addition to permanent FCI, does
ZEB1 play a role in other types of hypoxic-ischemic-mediated
injury, in particular ischemia/reperfusion injury (i.e. in the context
of increased reactive O2 species in vivo) and traumatic brain
injury, as well as in other neuro-degenerative diseases? In this
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involving the transcriptional repressor SLUG, [35], it is possible
that, in a certain cellular and patho-physiological contexts, ZEB1
could be a direct target of p53 itself. Third, in addition to p63-
mediated transcriptional induction, what other mechanisms,
transcriptional or otherwise, play a role in vivo in the dramatic
ischemia-mediated increase in ZEB1 protein levels (not to mention
the mechanistic basis for the rapid induction of p63). Lastly, in
addition to p73, which other pro-death genes/pathways are
targeted by ZEB1?
We have presented compelling evidence that ZEB1 induction is
part of a protective response by neurons to ischemia. The
fundamental nature of this pathway in cortical neurons is
underscored by its phylogenetic and developmental conservation.
The extent to which this survival pathway is utilized by other
tissues and/or in other patho-physiological contexts remains to be
seen.
Methods
Induction of permanent focal cerebral ischemia
All procedures and manipulations involving animals were
carried out in accordance with Emory University Institutional
Animal Care and Use Committee guidelines. The procedure,
employing either a suture embolism (sized in proportion to the
weight of the animal) of the mid-cerebral artery (MCA) in P7 rat
pups, or electro-coagulation of that artery in adult rats, has been
described in detail [23,40]. Animals were sacrificed and perfused
as described [40], and brains harvested for processing at 1, 1.5, 3,
6, 12, 24, 48, and 72 hrs after induction of FCI.
Isolation of primary cortical cultures
Primary cultures of rat or mouse cortical neurons were isolated
as described [41] and plated onto poly-D-lysine-coated (60 mg/ml)
coverslips or tissue culture wells. Cortical neurons derived from
ZEB1 KO mice were plated onto dishes coated with both poly-D-
lysine and laminin (10 mg/ml, SIGMA # L2020). All primary
cortical cultures were used from 4 to 6 DIV (days in vitro), with the
exception of neurons used for excitotoxicity studies, which were
cultured for 14–18 DIV before excitotoxic challenge.
Isolation of total RNA
Dissected cortices were briefly rinsed in sterile PBS, immediately
homogenized in Tri-reagent (SIGMA), and total RNA isolated
according to the manufacturer’s protocol. Total RNA was isolated
from tissue culture cells using the RNAqueous-4PCR kit (Ambion)
according to their protocol.
RT-PCR
50 ng of DNAse-treated total RNA isolated from normal, sham,
ischemic, or control P7 rat cortexes was used in 50 ml reaction
with of the primer pairs (0.6 mM final concentration; for primer
sequences see supplemental procedures) in a one-step RT-PCR
reaction buffer (Qiagen) according to the manufacturers protocol.
Cycling parameters for all samples were as follows: 50u, 30 min.,
one cycle; 95u,1 5 9, one cycle; 94u, 1 min.; either 58u(TAp63,
p63b and DNp73) or 60u(ZEB1 and DNp63) or 65u (p63a,
p63c,TAp73 and b-actin); 72u 1 min., 35 cycles; 72u. 10 mins, one
cycle. To control for the presence of contaminating genomic
DNA, a PCR-only reaction using identical conditions was carried
out (-RT lane, Figure 2b) using these samples. For positive
controls, 0.1 ng of plasmid DNA harboring the full-length cDNA
for a particular p63 isoform was used as the template in an
identical reaction.
Isolation of protein
Tissue samples from cerebral cortex were removed and
homogenized in a lysis buffer containing 20 mM Tris [pH 7.4],
150 mM NaCl, 1 mM EDTA, (TNE Buffer) 1 mM EGTA, 1%
Triton, 0.1% SDS, and a protease inhibitor cocktail (PI),
comprising 5 mM phenylmethylsulfonyl fluoride, and 10 mg/mL
each of the protease inhibitors antipain, chymostatin, pepstatin,
and leupeptin. Samples were then sonicated for 3615 s and
cleared by centrifugation at 12,0006g for 20 min at 4Cu. For
isolation of total protein from cultured cells, homogenates were
prepared in TNE buffer (with PI), 1% SDS, 0.25% Na2Deox-
ycholate, and 0.25% NP-40, and cleared as above. The protein
concentration of the supernatant was measured using Protein
Assay Reagent (Bio-Rad).
Western blotting
Western blots were performed using standard protocols [41,42].
To visualize ZEB1 protein, which, due to its net negative charge
(pI=4.73), has a significantly reduced electrophoretic migration
rate, samples were loaded onto 4–20% gradient gels. After transfer
of protein to nitrocellulose, blocking, incubation with appropriate
antibodies and extensive washing steps, target proteins were
visualized using chemilumenescence (Pierce). Membranes were
stripped using Strip-EZ reagent (Pierce), tested for absence of
signal, and re-probed and developed as above.
Recombinant DNA constructs, PCR primers, and
Oligonucleotides
All recombinant DNA expression and reporter constructs were
synthesized and purified according to standard protocols [42].
Oligonucleotides (with or without modifications) were obtained
from Integrated DNA Technologies (IDT, Coralville, Iowa).
Correct reading frames and sequences for all recombinant
constructs were verified by sequencing in both directions at
Emory University’s DNA Sequencing Core Facility.
The murine ZEB1 cDNA was fused in frame with GFP at its
carboxyl end, to create pCMVZEB-GFP, by synthesizing a full-
lengthZEB1PCRproductwithXhoIand BamHIrestrictionsitesat
the 59 and 39 ends, respectively; Top 59– CGACTCGAGCCTC-
GAGCCACGACCATGGCGGATGGCCCCAGGTGTAAGCG-
39; Bottom 59-CCACGTCTCGGATCCAGCTTCATTTGTCT-
TCTCTTCAGACAGCTGC-39, and inserting the gel-purified
digestion product into the CMV promoter-driven expression vector
pEGFP-N1 (CLONTECH). PCR synthesis of mouse ZEB1
promoter fragments were carried out using the bacterial artificial
chromosome RP23-345J21 (BACPAC Resources, Children’s Hospi-
tal Oakland Research Institute, Oakland, CA) as a template, and the
following primer sets: pmZPRO1300LUC, Top, 59-CAGTCAA-
GCTTGGGAGAAGGGTCAACTTAAGTCCCTA-39; pmZPRO-
700LUC, Top, 59-CAGTCAAGCTTTGGCAAGTCACTA-
CAACCCTGAGT-39 the Bottom primer for both was 59-
CAGTCAGTCGACTCCTCTCGCTTGTGTCTAAATGCT-
CG-39. The top primers incorporated a HindIII site, and the bottom
a SalI site. The gel-purified PCR products were restriction digested,
re-purified, and then cloned into the luciferase reporter plasmid
pGL3-Basic (Promega). The p53-family binding site was mutated
using the Quick Change II site-directed mutagenesis kit (Stratagene)
and a double-stranded primer pair with the sequence: TOP-59
catctggaataacaa AcGgcAtCgA cActTgaCgT caacaataaaaggac (plus
thereverse complement), (p53binding site is underlined with mutated
bases in lower case). Primer pairs crossing intron 1 of the mouse
ZEB1 gene for RT-PCR analysis were as follows: Top, 59-
TGTAAGCGCAGAAAGCAGGCGAA-39; Bottom, 59-
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r R N A :T o p ,5 9- CGGCTACCACATCCAAGGGAA -39,B o t t o m ,
59- GCTGGAATTACCGCGGCT – 39.
For the ZEB promoter ChIP analysis, primers encompassing the
p53 binding site in the rat ZEB1 promoter region (21160 to 2778
relative to the transcriptional start site, yielding a 382 bp product)
were: Top, 59- GGAAAGATCTCCCATGCTCATGG -39,
Bottom, 59 CCATTGGATGGTTTTGGCTCCTTTG -39. For
the human p73 promoter ChIP analysis, primers flanking five
ZEB1 binding sites [31] in the human p73 intron 1 promoter
region (2965 to 2377 relative to the transcriptional start site,
yielding a 588 bp product) were: Top, 59- GGGACCTGAGC-
CACCTCCAGGTCCCGG-39, Bottom, 59- CGGTGGAC-
TGGGCCATCTTCCCCACGCC-39.
Primers used in the RT-PCR analysis of p63 isoform expression
in the ischemic cortex: TAp63, Top, 59- GCTGTTTCATA-
GAAACCCCATCTCATTTCTCCTGG-39, Bottom, 59-GCT
GTGTGGGCCTGGGTAATCTGTGTTGGAGGG-39; Del-
taNp63, Top, 59-CCTGGAAAGCAA TGCCCAGACTCAATT-
TAGTGAGCC-39, Bottom, Same as for TAp63. Top primer for
p63alpha, p63beta, and p63 gamma, 59- AAGAGACCGGAA-
GGCCGATGAAG-39; p63alpha, bottom, 59- ACGGGGTGG-
GAAAGAGATGGTC-39; p63beta, bottom, 5- TCAGACTTGC-
CAA ATCCTGACA-39; p63gamma, bottom, 59- CTCTCCGG-
GACTCCACAAG. Beta-actin primers, Top, 59- TCTGTG-
TGGATTGGTGGCTCTA-39, Bottom, 5- CTGCTTGCTGA-
TCCACATCTG-39.
Double-stranded oligonucleotides used in the microtitre-plate-
based p63-ZEB1 promoter binding assays were as follows: wt
oligo, (biotinylated and incorporating the p53-family binding site
from the ZEB1 proximal promoter), TOP, 59-acaatAGGATAGC-
TAAAACTATCCTatctc-Biotin–39 (p53 binding site is capital-
ized); wt competitor oligo, same as wt without the 39 biotin;
mutant oligo, TOP, 59- acaat AcGgcAtCgA cActTgaCgT atctc-39;
non-specific oligo, TOP 59- acaatATCGGCATATGCATCGAG-
Catctc-39.
Histology
Antibodies used in these studies: I. Primaries. A rabbit
polyclonal antibody specific for ZEB1 was generated and affinity
purified commercially (New England Peptides, Inc.) using the
following peptide: Ac-LETNQASLASKEQEAVS-Amide
(corresponding to amino acids 409 to 425 of the mouse ZEB1
protein). The mono-specificity of this antibody was verified by the
presence of a single band on western blots of whole brain lysates
from both mouse and rat, (which could be competed away using in
vitro-translated full-length ZEB1 protein [not shown]), as well as
by the experiment described in Figure S1. For immunostaining
paraffin sections the anti-ZEB1 Ab was used at 1:000 dilution, for
frozen sections, 1:600, for western blots, 1:5000, for chromatin
immunoprecipitation, 1:400. NeuN: Chemicon, MAB377, at
1:250 dilution; active Caspase 3: Cell Signaling Technology, at
1:500; p63, for immunostaining and chromatin
immunoprecipitation assays: the pan-anti-p63 monoclonal Ab
4A4, Novocastra, 1:250, for western blots, p63TA isoform: Santa
Cruz, sc-8608, at 1:500, p63DeltaN isoform: Santa Cruz, sc-8609,
at 1:750; p73, for immunostaining: Santa Cruz, sc-7957, p73TA
isoform, Calbiochem OP108, at 1:450, p73DeltaN isoform,
Abcam ab13649, at 1:750; PUMA, Cell Signaling Technology,
at 1:800; b-actin, Santa Cruz sc-1615 at 1:1000; a-Tubulin, Santa
Cruz sc-23948. II. Secondaries. For colorimetric
immunostaining, a biotinylated horse radish peroxidase-coupled
secondary antibody appropriate for the particular primary was
used at 1:100 dilution: Vector Labs, ABC Elite Staining Kit. For
double-immunofluorescence staining, an Alexa-Fluor-coupled
secondary antibody appropriate for a particular primary Ab was
employed, green: Alexa 488, red: Alexa 594, all from Molecular
Probes/Invitrogen. For western blotting, stabilized secondary
antibodies were purchased from Pierce: anti-rabbit,1:500,000
dilution; anti-mouse, 1:200,000).
Immunostaining
10 mm frozen coronal sections derived from formalin-fixed P7
or adult rat brains were prepared as described [40]. The
procedure for staining paraffin sections of human autopsy brain
tissue was identical to that described above for frozen sections,
except they were subjected to de-waxing, re-hydration, and
antigen unmasking (3659 at full power in a 750 Watt microwave
in 10 mM Na2 citrate) before the permeablization step. Following
a2 0 9 permeablization step (0.2% Triton-X 100 in PBS) and
blocking of endogenous peroxidase (4% H2O2, 50% methanol)
non-specific binding sites were blocked (3% BSA, 5% goat serum
in PBS), and incubated with primary antibody in 0.56 blocking
buffer supplemented with 0.1% Triton–X 100 overnight at 4u.
After three 159 washes in PBS, sections were incubated with
secondary Ab in the same buffer used for the primary for 1 hour at
RT. Following three 159 washes in PBS, antigen was visualized
using the chromogenic substrate 3-39 diaminobenzi-dine (for
HRP-coupled secondaries). For quantification of colorimetric
staining of tissue sections or fixed cells, densitometry was
performed on scanned, digitized images using the Image J
software program (NIH). The use of archived pathology samples
of human tissue for immunostaining in these studies was exempted
by the Emory University School of Medicine Institutional Review
Board (# 679-2004). The procedure for staining paraffin sections
of human autopsy brain tissue was identical to that described
above for frozen sections, except they were subjected to de-waxing,
re-hydration, and antigen unmasking (3659 at full power in a 750
Watt microwave in 10 mM Na2 citrate) before the permeabliza-
tion step.
Treatment of Primary Cortical Cultures with Pro-death
Insults
To test the ability of ZEB1 to protect primary cortical neurons
(4–6 DIV; in the case of excitotoxicty challenge, 14–16 DIV) from
death-inducing insults, cells were transfected with either EGFP
alone or the ZEB1-EGFP fusion protein (Lipofectamine 2000
(GIBCO) at a ratio of 0.8 mg DNA:4 ml reagent per well of a 12-
well plate, according to the manufacturers protocol), and returned
to the incubator for 24 hrs. At this time, the following death/
apoptosis-inducing agents were used at the concentrations or doses
specified: hydrogen peroxide, 75 mM final concentration; Gluta-
mic acid, 500 mM final, made fresh; the nitric oxide (NO) donor,
S-nitrosoglutathione (GSNO/SNOG), 250 mM final; TNF-a,
10 ng/ml final; a 10 Grey dose of gamma ionizing radiation
(IR) generated from a Cesium source; or DMSO vehicle. Neurons
kept between 14 and 16 DIV were subjected to oxygen-glucose
deprivation by changing the normal neurobasal-based plating
media to osmotically-balanced salts without glucose (116 mM
NaCl, 5.4 mM KCl, 0.8 mM MgSO4, 1.8 mM CaCl2, 20 mM
HEPES-NaOH, pH 7.4, sterile-filtered) and then placing them in
a humidified, gas-impermeable chamber (Billups-Rothenberg,
Inc.), and introducing a 95%N2/5%CO2 gas mixture into the
inflow port until an oxygen sensor (PROOX 110, BioSpherix,
Ltd.) attached to the outflow port registered less than 0.5%
oxygen. The sealed chamber was then placed at 37u for the
duration of the experiment. To prevent even momentary re-
oxygenation (re-perfusion) of the cells upon their removal for
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impermeable glove box and opened under anoxic conditions.
Following the various treatments, neurons were returned to 37u
(in the case of the H2O2 treated cells, media was switched after 309
to normal; the OGD-treated cells were returned to an O2-depleted
atmosphere as described below), and individual coverslips were
removed at 09,3 0 9, 1 hr, 2 hr, 4 hr, and 8 hr, and 16 hr., to assess
the relative cellular damage. To measure mitochondrial mem-
brane integrity (Figure 3, bottom; and S4), cells were processed
using the Image-iT LIVE kit (Molecular Probes/Invitrogen,
according to the manufacturer’ instructions. This method employs
the cell-permeable Mitotracker Red CMXRos dye, that is only
taken up and retained by mitochondria with an intact membrane
potential. Though not dispositive (cells losing mitochondrial
membrane potential either through the opening of the permeabil-
ity transition pore or through other means have been shown to
recover from apoptotic insults), neurons taking up and retaining
this dye were scored as ‘‘healthy’’ compared with their dye-
negative counterparts, by counting ten separate fields on each slide
by two individuals in a blinded fashion. To assess the relative
health of nuclei from these cells (Figure 3, top; and S3), parallel
cultures were stained with Hoechst 33342 dye (Molecular Probes/
Invitrogen) and neurons with pyknotic/shrunken/fragmented
nuclei (a hallmark of dying cells) as compared with ‘‘healthy’’
nuclei (normal, rounded morphology, indistinguishable from
untreated control cells) were scored in a similar fashion as with
the mitochondrial dye. Cells were scored for the presence of
double-stranded DNA breaks employing a rhodamine-coupled
detection assay (TdT-based TUNEL-staining kit, Roche). TU-
NEL-positive cells were scored by dividing the GFP-rhodamine
double-positive cells by the total number of rhodamine-positive
cells in a given field. In all cases, ten separate fields were counted
on each slide by two individuals in a blinded fashion (Figure S5).
Transfections/Transductions/Luciferase Assays
Primary cultures of cortical neurons were transiently transfected
with Lipofectamine 2000, and the osteosarcoma cell line SAOS-2
(Figure 5b) was transiently transfected with FUGENE 6, each
according to the manufacturers instructions. Neurons were
transduced with lentiviral constructs (amplified and concentrated
at the Emory University Department of Neurology’s Center for
Neurodegenerative Disease’s Viral Vector Core) at an M.O.I of
between 1 and 5, depending on the construct. We routinely
achieved transduction efficiencies of between 90% and 95%.
SAOS-2 cells were lysed and assayed for reporter firefly Luciferase
activity using the Luciferase Assay Reagent Kit (Promega), with a
Renilla Luciferase reporter construct as the normalization control.
Genotyping embryos
To genotype mouse embryos (or primary neurons in culture), a
small portion of tissue from each embryo was aseptically removed
at the time of dissection (taking care to eliminate cross-
contaminating tissue from the dam or littermates), and genomic
DNA isolated according to standard protocols [42]. To test for the
presence of the wt ZEB1 allele, 1 ng of genomic DNA was
subjected to the following PCR protocol: 94u for 3 minutes, for
one cycle; 94u, 1 minute, 62u, one minute, 72u, one minute, for 37
cycles; 72u, 10 minutes, one cycle, using the following primers:
Top, 59 –ATGTCGTAAAGCCTCGAGTGTCGT – 39 Bottom,
59 - AGCAAGAGTGGAGAAAGTGCGGAA - 39, the resulting
526 reaction product visualized on a 2% agarose gel. A separate
PCR reaction was carried out to test for the presence of the LAC-
Z cDNA (knocked into the ZEB locus [19],: 94u for 3 minutes, one
cycle; 94u, 1 minute, 65u, one minute, 72u, one minute, 35 cycles;
72u, 10 minutes, one cycle, using the following primers: Top, 59 –
TAGGTGTTAGGAAGGTGATGTCG – 39; Bottom, 59 –
AACCGTGCATCTGCCAGTTTGAG - 39. The resulting
389 bp product was also visualized on a 2% agarose gel.
Quantitative RT-PCR
The ZEB1 primer pair (TOP: 59 - TGTAAGCGCAGAAAG-
CAGGCGAA - 39; BOT: 59 – ACAGTATTACCAGGAGGCT-
GAGAC – 39) produced a single PCR product of expected size -
204 bp - using total RNA isolated from E16.5 or P7 rat cortex as a
template, and no product using a 1 mg of a plasmid harboring a full-
length cDNA encoding the closely-related SIP1 cDNA (a kind gift
from D.Huylebroeck,[39])asthetemplate;thecontrolSIP1primer
pair (TOP, 59 - CAATGACTATAAAGTTCTTATGGCAACA-
CATGGGTTTAGTGG – 39; BOT: 59 - CCGACAGGGGGAA-
TATTGGGAGAAGTTACCCCTTGTTCT), produced a unique
498 bp product (see Figure S6); the 18S rRNA primer pair yielded
an amplicon of 181 bp. Starting with either cortical- or primary
cortical cell culture-derived total RNA (isolated using the RNAqu-
eous Kit and DNAse I-treated with DNA-free reagent, both
Ambion) as a template, RT-PCR was performed using a SYBR
Green-based one-step protocol (QuantiTec SYBR Green RT-PCR
kit, Qiagen), in a SMART-CYCLER II PCR machine (Cepheid,
Inc.) using the following run parameters: RT step, 50u, 30 minutes;
PCR step, 95u, 15 minutes, one cycle, 95u, 5 seconds, 60u,
15 seconds, 72u, 30 seconds, 45 cycles. The reaction mixture
(25 ml) included 10 ng total RNA (determined by absorbance at
260 nm in H2O), 12.5 ml2 6 Quantitect SYBR Green RT-PCR
Master Mix, and 500 nM each primer. For either set of primer
pairs, melting curve analysis (60u to 90u at 0.2u/sec) showed a single
specific reaction product. For absolute quantification of ZEB1,
RNA standards were synthesized by T7 polymerase-mediated in
vitro transcription of the full-length mZEB1 cDNA (Megascript Kit,
Ambion). Following treatment with DNase I to remove plasmid
DNA, the integrity of the RNA was verified on an agarose gel,
quantified spectrophotometrically (A260), and stored at a concen-
tration of 10
10 transcripts/ml at 280u. Serial dilutions of this
standard, ranging from 50 to 56(10)
6 transcripts were run
concurrently with each ZEB1 RT-PCR reaction above and used
to generate a standard curve. Thiswas used to convert the threshold
cycle values from each run to ZEB1 message copy number based
the weight of input RNA (normalized to 18S rRNA levels in a
separate RT/PCR run under identical conditions, adjusting for a
proportionate dilution of the input RNA to broaden the dynamic
range of this analysis for this very highly abundant RNA). Samples
were done in triplicate within each run and at least four separate
runs were conducted per treatment. Excluding the outlier value of
each triplicate, individual means from each run were determined
and the combined mean number of transcripts+/2the S.E.M./mg
input RNA was plotted.
Microtitre plate-based analysis of DNA-protein
interactions
The basic protocol derived from the No-Shift kit (Novagen, Inc.)
was modified as follows. Full-length mouse p63 cDNAs for
encoding TAp63a, DNp63c (kind gifts of Frank McKeon);
DNp63a and DNp63c (kind gifts of Anil Rustgi); and TAp63b
and DNp63b (kind gifts of David Sidransky and Barry Trink) were
in vitro transcribed/translated using the TnT kit (Promega).
Equimolar amounts of these full-length proteins for use in the
DNA-binding assay were obtained by comparing, via densitom-
etry, parallel TNT reactions (western blotted and visualized using
a strepavidin-conjugated HRP chemi-luminescent detection sys-
tem) incorporating biotinylated lysine residues (Transcend kit,
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biotinylated translation product (adjusting for the relative number
of lysine residues in each full length translation product). Double-
stranded oligos (with or without increasing amounts of competitor
oligo) were first incubated for 1 hr on ice with approximately
50 ng of the TnT-generated protein (with appropriate binding
buffer and competitor DNA from kit), bound to streptavidin-
coated wells in a micotire plate for 1 hr at 37u, washed extensively,
then incubated for 30 minutes at 37u with a 1:500 dilution of anti-
p63 (monoclonal 4A4, SantaCruz). Following incubation with a
anti-mouse-HRP conjugated secondary Ab (diluted 1:1000), a
colorimetric substrate from the kit was added, allowed to develop
for 259, and read at A450 nm in a plate reader (Synergy-HT, Bio-tek
Corp.). (for sequences see Recombinant DNA constructs
PCR Primers, and Oligonucleoitdes, above)
Chromatin immunoprecipitation assay
E16–E17 derived mouse primary cortical cultures (isolated as
described above and plated at 5610
4/ml) were subjected to OGD
for the times indicated, approximately 1610
6 cells per time point
per experiment (two, 10 cm plates). Normoxic controls and OGD-
treated cells (without re-exposure to normoxia) were subjected to
formaldehyde cross-linking (1% final, 209) by direct addition to the
tissue culture medium. Cells were harvested in ice-cold PBS,
gently pelleted and re-suspended in 1 ml lysis buffer (5 mM
PIPES, (8.0), 85 mM KCl, 0.5% NP40, plus protease inhibitors
(PI) as above). After a second gentle spin (30006g, 59,4 u), cell
pellet was resuspended again in 1 ml lysis buffer, and incubated on
ice, 59. Cells were re-spun (30006g, 59,4 u), supernatant discarded,
and nuclear pellet resuspended in 0.5 ml nuclear lysis buffer
(50 mM Tris-HCl (8.0), 10 mM EDTA, 1% SDS+PI), and
incubated on ice for 309, with vortexing every 109. Debris was
pelleted by spinning at 20,0006g for 209,a t4 u and the nuclear
lysate was removed for shearing of DNA.
To process P7 rat pup brain, at a given time point following the
administration of unilateral MCAO, animals were sacrificed,
ischemic-side or sham-operated cortexes ware rapidly dissected out,
placed in a weigh boat on ice, immediately minced into 1 mm pieces
and transferred into a microfuge tube. Following cross-linking by
incubatingin1% formaldehyde inPBS (159,3 7 u), tissue was washed 5
times with ice-cold PBS. Tissue was then homogenized (Mini-
homogenizer, Biospec Products, Bartlesville, OK) in 1 M sucrose,
10 mM Hepes [pH 7.9], 10 mM KCl, 3 mM MgCl2, (plus PI as
above) and centrifuged in a microfuge at 2000 rpm, 109,4 u to pellet
cellular debris. The supernatant was then re-centrifuged at
11,000 rpm, 109,4 u. The resulting nuclear pellet was reuspended
in 10 mM Hepes [pH 7.9], 0.4 MNaCl, 3 mMMgCl2, 0.5 mM
DTT, and incubated in ice for 309, with vortexing every 109.D e b r i s
was pelleted by spinning at 20,0006gf o r2 0 9,a t4 u and the nuclear
lysate was removed for shearing of DNA.
The ChIP procedure was carried out basically as described by
Beresford, et. al. [43] with the following modifications. Nuclear
lysates were sonicated using a Sonic-Dismembrator 60 (Fisher)
fixed with a microprobe set at 50% power for 5620 sec bursts on
ice to an average chromatin fragment size of 600 bp (verified by
running a reversed cross-linked aliquot on an agarose gel). 50 mlo f
the chromatin supernatant was pre-cleared by adding it to 950 ml
of IP buffer (0.01% SDS, 1.1% Triton –X 100, 20 mM Tris-Cl
(8.0), 1.2 mM EDTA, 167 mM NaCl) plus 100 ml of solution A (a
50% slurry of protein A Sepharose (Cl-4B, Amersham) in 10 mM
Tris-Cl(8.0), 1 mM EDTA, 50 ml normal mouse serum, 0.2 mg/
ml tRNA, 0.2 mg/ml salmon sperm DNA), and rotated 1 hr., 4u.
After pelleting and discarding the protein A beads (30006g, 59,
4u), 5 mg of an appropriate antibody (either anti-p63 or anti-ZEB1)
was added to the supernatant and the mixture rotated overnight at
4u. For negative controls, chromatin preparations were incubated
with a-tubulin (heterologous, non-specific Ab) as well as without
antibody. The following day, the immune complexes were
immunoprecipitated by adding 60 ml of the above protein A
slurry/BSA/SS DNA/tRNA mixture, rotating 1 hr, 4u, followed
by gentle pelleting (30006g, 59,4 u). Supernatants were carefully
removed, with the minus Ab control supernatant retained for use
as a positive control in the subsequent PCR analysis. Pellets were
washed by rotating for 109 at 4u, with 361 ml of each the
following buffers: IP buffer, TSE-500 buffer (0.1% SDS, 1%
Triton X-100 2 mM EDTA, 20 mM Tris-HCl (8.0), 500 mM
NaCl), LiCl buffer (100 mM Tris-Cl (8.0), 500 mM LiCl, 1% NP-
40, 1% deoxycholic acid), and TE. Macromolecular complexes
were eluted from the Protein A beads with 26250 mlo fE B
(50 mM NaHCO3, 1% SDS). Formaldehyde crosslinks were
reversed by incubating eluates (including 400 ml of the minus Ab
negative control) at 65u o/n after addition of 20 ml 5 M NaCl.
DNA was purified from the eluted complexes by the addition of
Proteinase K, followed by phenol/chloroform extraction. After
addition of carrier, chromatin fragments were EtOH precipitated,
washed and resuspended in 30 ml water. One-tenth of this DNA
solution (or 1/1000
th of the positive control supernatant) was used
for PCR amplification (95u, 15 mins, one cycle, 95u, 5 seconds,
61u, 15 seconds, 72u, 30 seconds, 40 cycles). ChIP assays for p63
binding and ZEB1 binding were each carried out three times.
Supporting Information
Figure S1 Specificity of the anti-ZEB1 antibody used in these
studies. Full-length ZEB1 and the closely-related SIP1/ZEB2 35S-
labeled in vitro translation products were separated via SDS-
PAGE and immunoblotted using the anti-ZEB1 polyclonal
antibody; left panel (labeled 35S), 24 hr exposure of the nylon
membrane, revealing the 35S labeled protein bands; right panel
(labeled WB), 5 min chemilumenescent exposure of the same blot
after immunoblotting.
Found at: doi:10.1371/journal.pone.0004373.s001 (0.24 MB TIF)
Figure S2 Double-immunofluorescence staining of rat P7
ischemic cortex 12 hours post-FCI. ZEB1-positive neurons and
cells staining positive for either active Caspase 3 (Top row) or the
BH3-only Bcl-2 pro-apoptotic family member PUMA (Bottom
row) are mutually exclusive. Scale bar=50 mm.
Found at: doi:10.1371/journal.pone.0004373.s002 (1.45 MB TIF)
Figure S3 Over-expressed ZEB1 mitigates cellular damage/
death in primary cortical neurons subjected to a battery of toxic
insults: effect on nuclear morphology. Primary cultures of cortical
neurons were co-transfected with either GFP alone (White Bars) or
a full-length cDNA for ZEB1 fused to GFP (Blue Bars). Eighteen
hours later cells were subjected to a battery of pro-death/toxic
insults (for details, see Materials and Methods). GFP-positive
neurons were processed and scored (in a blinded fashion) for
having either a normal vs a pyknotic/mis-shapen/condensed
morphology. In this example, representative photomicrographs of
cells challenged with OGD for 6 hrs indicate that a greater
percentage of ZEB1-transfected cells are over twice as likely to
retain a rounded ‘‘normal’’ nuclear morphology, than those
transfected with GFP alone (panels d and e). For every
administered insult (except nitric oxide - see text) in an acute
time-frame, and in a dose-dependant manner, nuclei of ZEB1-
transfected neurons maintained a ‘‘normal’’, rounded morpholo-
gy. Results for six different insults are summarized graphically in
Figure 3. In both panels, a. GFP alone; b. GFP plus Hoechst; c.
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bars, a–c=50 mm; d,e=10 mm.
Found at: doi:10.1371/journal.pone.0004373.s003 (1.64 MB TIF)
Figure S4 Over-expressed ZEB1 mitigates cellular damage/
death in primary cortical neurons subjected to a battery of toxic
insults: effect on mitochondrial membrane integrity. Primary
cultures of cortical neurons were co-transfected with either GFP
alone (White Bars) or a full-length cDNA for ZEB1 fused to GFP
(Blue Bars). Eighteen hours later cells were subjected to a battery
of pro-death/toxic insults (for details, see Materials and Methods).
GFP-positive neurons were processed and scored (in a blinded
fashion) for either intact (rhodamine stain) or compromised
(absence of rhodamine stain) mitochondrial membranes. In this
example, representative photomicrographs of cells challenged with
OGD for 6 hrs indicate that a greater percentage of ZEB1-
transfected cells maintain mitochondrial integrity, than those
transfected with GFP alone (panels h and i). For every
administered insult (except nitric oxide- see text) in an acute
time-frame, and in a dose-dependant manner, mitochondrial
integrity in ZEB1-transfected neurons was maintained relative to
neurons transfected with GFP alone. Results for six different
insults are summarized graphically in Figure 3. In both panels, a,
phase contrast; b. GFP-positive cells; c. TMRhodamine-red-
positive cells, indicating intact mitochondria; d. Hoechst staining
of nuclei; e. phase plus GFP; f. GFP plus TMR-red; g. GFP plus
Hoechst; h. triple stain; i. magnification of indicated area in panel
h. Scale bars, a–h=50 mm; I=20 mm.
Found at: doi:10.1371/journal.pone.0004373.s004 (4.08 MB TIF)
Figure S5 Over-expressed ZEB1 protects primary cortical
neurons from OGD-mediated cellular damage/death: time course
of TUNEL-labeling. Primary cultures of cortical neurons were co-
transfected with either GFP alone (White Bars) or a full-length
cDNA for ZEB1 fused to GFP (Blue Bars). Eighteen hours later,
cells were subjected to OGD for the times indicated, fixed under
hypoxic conditions, and GFP-positive cells were scored for
TUNEL staining in a blinded fashion. Consistent with the results
from Figure 3, over-expressed ZEB1 reduced the average number
of TUNEL-positive cells by less than half at the 12 hr time point.
Results shown are the average of three separate experiments
(cultures isolated on different days)+/2the S.E.M.; *=P,0.01 by
Student’s T-test.
Found at: doi:10.1371/journal.pone.0004373.s005 (9.48 MB TIF)
Figure S6 Oxygen-glucose deprivation increases steady-state
levels of ZEB1 mRNA in primary neuronal cultures. (A) Top
Panel, Primers used in this analysis (see Materials and Methods for
sequences) cross intron 1 of the mouse ZEB1 gene to yield a
204 bp PCR product. Bottom Panel, Control PCR reactions
demonstrating ZEB1 primer specificity. Lane 1, 498 bp SIP1 PCR
product derived using SIP1-specific primers and SIP1 cDNA
template; lane 2, 1 mg SIP1 cDNA template with ZEB1-specific
primers; lane 3, 204 bp product derived using ZEB1-specific
primers with 1fg ZEB1 cDNA template; lane 4, 204 bp RT-PCR
product using ZEB1-specific primers and 10 ng total RNA isolated
from an E16.5 rat primary cortical culture; lane 5, same as 4
minus RT; M, 100 bp incremental markers. (B) Quantitative RT-
PCR results using indicated ZEB1-specific primers and 10 ng total
RNA isolated from E16.5-derived primary cortical cultures
subjected either to normoxia or OGD (3 hrs. with RNA harvested
under hypoxia). Values are numbers of transcripts of ZEB1
mRNA (derived from a standard curve generated concurrently in
the same PCR run) per mg of input total RNA.
Found at: doi:10.1371/journal.pone.0004373.s006 (0.45 MB TIF)
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